Therapeutic aspects of the Axl/Gas6 molecular system

Rossella Di Stasi1, Lucia De Rosa1, Luca D D'Andrea2

  • 1Istituto di Biostrutture e Bioimmagini, CNR, Via Mezzocannone 16, 80134 Napoli, Italy.

Drug Discovery Today
|October 1, 2020
PubMed

Insights

The Axl/Gas6 molecular system is crucial in cancer and autoimmune diseases. Targeting this axis offers therapeutic potential but faces challenges in drug development.

Area of Science:

  • Molecular Biology
  • Drug Discovery
  • Oncology

Background:

  • The Axl receptor tyrosine kinase (RTK) and its ligand, growth arrest-specific protein 6 (Gas6), play significant roles in various biological processes.
  • Dysregulation of the Axl/Gas6 axis is implicated in the pathogenesis of numerous cancers and autoimmune disorders.

Purpose of the Study:

  • To review the Axl/Gas6 molecular system from a drug discovery viewpoint.
  • To highlight therapeutic implications and challenges associated with targeting the Axl/Gas6 axis.
  • To provide an updated overview of Axl/Gas6 axis biology and its diverse roles.

Main Methods:

  • Literature review of Axl/Gas6 axis biology.
  • Analysis of therapeutic strategies targeting the Axl/Gas6 pathway.
  • Summary of current drug candidates for Axl/Gas6 modulation.

Main Results:

  • The Axl/Gas6 axis is involved in critical cellular functions including angiogenesis, cancer progression, metastasis, immune response, inflammation, and viral infections.
  • Several molecular entities have been developed to target the Axl/Gas6 system.
  • Therapeutic and diagnostic applications are being explored for Axl/Gas6-targeting agents.

Conclusions:

  • The Axl/Gas6 axis represents a promising target for therapeutic intervention in various diseases.
  • Further research and development are needed to overcome challenges in Axl/Gas6-targeted drug discovery.
  • Targeting the Axl/Gas6 pathway holds potential for novel treatments in oncology, immunology, and infectious diseases.